Friday, 16 November 2012

Rare mutation linked to Alzheimer's

Two separate studies published online this week, by the New England Journal of Medicine, both point to a link between Alzheimer's disease and a rare gene mutation. The mutation in question is known to affect the immune system's response to inflammation. This discovery supports an emerging theory about the role played by the immune system in the development of Alzheimer's disease.

One of the teams was led by John Hardy of University College London, and the other led by the Iceland-based global company deCode Genetics.

Both teams concluded that a rare mutation in a gene called TREM2, which helps to trigger immune system responses, increases the risk of developing Alzheimer's disease. One of the studies suggests it raises the risk by three times, the other says four. The lead author of the UCL study, Rita Guerreiro, commented: "While the genetic mutation we found is extremely rare, its effect on the immune system is a strong indicator that this system may be a key player in the disease."

In the UCL-led study, researchers from 44 institutions from around the world analysed data from a total of 25,000 people. They used new sequencing techniques to home in on the TREM2 gene, and then used more sequencing to identify a set of rare mutations. They then discovered that the mutations were more prevalent in the 1,092 Alzheimer's patients than in the 1,107 healthy controls. The co-author, Minerva Carrasquillo, said "In our series, it was present in 1.9 percent of the Alzheimer's patients and in only 0.37 percent of the controls."

Also the CEO and co-founder of deCode Genetics said: "The discovery of variant TREM2 is important because it confers high risk for Alzheimer's and because the gene's normal biological function has been shown to reduce immune response that may contribute to the disease." He went on to say that these factors make TREM2 an attractive target for drug development.

Jack

No comments:

Post a Comment